방사선생물학

본문글자크기
  • 2016년 10월호
    [ Int J Oncol.] The resveratrol analog HS-1793 enhances radiosensitivity of mouse-derived breast cancer cells under hypoxic conditions.

    DIRAMS, 동아의대/ 최유진, 양광모*, 정민호*

  • 출처
    Int J Oncol.
  • 등재일
    2016 Oct
  • 저널이슈번호
    49(4):1479-88. doi: 10.3892/ijo.2016.3647.
  • 내용

    바로가기  >

    Abstract

    Tumor hypoxia is associated with treatment resistance, cell proliferation, and metastatic potential, all of which contribute to a poor prognosis. Resveratrol [RES (trans-3,4',5-trihydroxystilbene)], a naturally occurring polyphenol, is enriched in grapes and red wine. This study investigated whether the resveratrol analog HS-1793 modulates the hypoxic status and the level of perfusion in mouse breast cancer FM3A cells. Our data show that HS-1793 decreased the levels of hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor protein under hypoxic conditions in FM3A cells. HS-1793 improved perfusion and hypoxic status in tumor tissues and inhibited angiogenesis through HIF-1α suppression in mice. Moreover, HS-1793 inhibited hypoxia-induced cancer stem cell properties and enhanced ionizing radiation-induced apoptosis in hypoxic FM3A cells. Collectively, the resveratrol analog HS-1793 might act as a potent radiosensitizer and be a useful adjuvant agent against radiotherapy-resistant hypoxic cells in solid tumors. 

     

    Author information

    Choi YJ1, Heo K1, Park HS1, Yang KM1, Jeong MH2.

    1Department of Research Center, Dong Nam Institute of Radiological and Medical Sciences, Busan 619-953, Republic of Korea.

    2Department of Microbiology, Dong-A University College of Medicine, Busan 602-714, Republic of Korea. 

  • 덧글달기
    덧글달기
       IP : 3.19.56.45

    등록